Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
70
GENI Quote, Financials, Valuation and Earnings
Last price:
$10.90
Seasonality move
:
15.64%
Day range:
$10.31 - $10.99
52-week range:
$5.60 - $11.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.74x
P/B ratio:
3.60x
Volume:
6.4M
Avg. volume:
5.2M
1-year change:
78.05%
Market cap:
$2.6B
Revenue:
$510.9M
EPS (TTM):
-$0.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $149.7M | $262.7M | $341M | $413M | $510.9M | |
| Revenue Growth (YoY) | 30.64% | 75.46% | 29.8% | 21.1% | 23.71% | |
| Cost of Revenues | $114.1M | $476.2M | $338.2M | $344M | $382.2M | |
| Gross Profit | $35.7M | -$213.4M | $2.9M | $69M | $128.7M | |
| Gross Profit Margin | 23.82% | -81.24% | 0.84% | 16.71% | 25.19% | |
| R&D Expenses | $11.2M | $26.5M | $29.9M | $26.1M | $24.6M | |
| Selling, General & Admin | $44.8M | $320.5M | $154.2M | $114.6M | $160.4M | |
| Other Inc / (Exp) | -$295K | -$40.7M | -$589K | -$13.6M | -$10.9M | |
| Operating Expenses | $56M | $347M | $184.1M | $140.7M | $185M | |
| Operating Income | -$20.4M | -$560.4M | -$181.2M | -$71.7M | -$56.3M | |
| Net Interest Expenses | $7.9M | $3.3M | $1.5M | -- | -- | |
| EBT. Incl. Unusual Items | -$28.5M | -$604.5M | -$183.3M | -$83.3M | -$66.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.8M | -$11.7M | $1.7M | $5.3M | $509K | |
| Net Income to Company | -$30.3M | -$592.8M | -$181.6M | -$85.5M | -$63M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$30.3M | -$592.8M | -$181.6M | -$85.5M | -$63M | |
| Basic EPS (Cont. Ops) | -$0.35 | -$3.79 | -$0.85 | -$0.38 | -$0.27 | |
| Diluted EPS (Cont. Ops) | -$0.35 | -$3.79 | -$0.85 | -$0.38 | -$0.27 | |
| Weighted Average Basic Share | $178.6M | $159.4M | $213.4M | $225.9M | $229.5M | |
| Weighted Average Diluted Share | $178.6M | $159.4M | $213.4M | $225.9M | $229.5M | |
| EBITDA | $14.4M | -$541.8M | -$112.7M | $5.6M | $16.3M | |
| EBIT | -$20.7M | -$601.1M | -$181.2M | -$71.7M | -$56.3M | |
| Revenue (Reported) | $149.7M | $262.7M | $341M | $413M | $510.9M | |
| Operating Income (Reported) | -$20.4M | -$560.4M | -$181.2M | -$71.7M | -$56.3M | |
| Operating Income (Adjusted) | -$20.7M | -$601.1M | -$181.2M | -$71.7M | -$56.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $53.7M | $85.9M | $97.2M | $119.7M | $144M | |
| Revenue Growth (YoY) | 51.94% | 59.89% | 13.16% | 23.13% | 20.28% | |
| Cost of Revenues | $40.1M | $101.4M | $87.7M | $106.9M | $108.8M | |
| Gross Profit | $13.6M | -$15.5M | $9.5M | $12.8M | $35.2M | |
| Gross Profit Margin | 25.36% | -17.98% | 9.8% | 10.7% | 24.45% | |
| R&D Expenses | $3.3M | $7.4M | $6.3M | $6.6M | $8.9M | |
| Selling, General & Admin | $12.8M | $42M | $25.5M | $30M | $45.9M | |
| Other Inc / (Exp) | -$852K | $25.6M | -$3M | -$1.6M | $11.5M | |
| Operating Expenses | $16M | $49.4M | $31.7M | $36.6M | $54.9M | |
| Operating Income | -$2.4M | -$64.9M | -$22.2M | -$23.8M | -$19.7M | |
| Net Interest Expenses | $2.3M | $391K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$5.6M | -$39.6M | -$24.8M | -$24.7M | -$7.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$263K | $576K | $648K | $1.1M | $542K | |
| Net Income to Company | -$5.3M | -$40.2M | -$25.2M | -$25.5M | -$8.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.3M | -$40.2M | -$25.2M | -$25.5M | -$8.2M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.21 | -$0.11 | -$0.11 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.21 | -$0.11 | -$0.11 | -$0.03 | |
| Weighted Average Basic Share | $178.6M | $195.8M | $221.7M | $229.3M | $248.4M | |
| Weighted Average Diluted Share | $178.6M | $195.8M | $221.7M | $229.3M | $248.4M | |
| EBITDA | $6.9M | -$21.7M | -$4.9M | -$2.7M | -$3.3M | |
| EBIT | -$3.2M | -$39.2M | -$22.2M | -$23.8M | -$19.7M | |
| Revenue (Reported) | $53.7M | $85.9M | $97.2M | $119.7M | $144M | |
| Operating Income (Reported) | -$2.4M | -$64.9M | -$22.2M | -$23.8M | -$19.7M | |
| Operating Income (Adjusted) | -$3.2M | -$39.2M | -$22.2M | -$23.8M | -$19.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $168.1M | $294.9M | $352.3M | $435.5M | $535.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $126.5M | $537.4M | $324.5M | $363.2M | $384.1M | |
| Gross Profit | $41.6M | -$242.5M | $27.8M | $72.3M | $151.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.1M | $30.6M | $28.8M | $26.4M | $26.9M | |
| Selling, General & Admin | $45.7M | $349.7M | $137.6M | $119.1M | $176.4M | |
| Other Inc / (Exp) | -$257K | -$14.2M | -$29.2M | -$12.1M | $2.2M | |
| Operating Expenses | $57.8M | $380.4M | $166.4M | $145.6M | $203.3M | |
| Operating Income | -$16.2M | -$622.9M | -$138.5M | -$73.3M | -$52.2M | |
| Net Interest Expenses | $8.3M | $1.4M | $678K | -- | -- | |
| EBT. Incl. Unusual Items | -$24.8M | -$638.5M | -$168.4M | -$83.2M | -$49.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.3M | -$10.9M | $1.8M | $5.8M | -$49K | |
| Net Income to Company | -$28.1M | -$627.6M | -$166.6M | -$85.9M | -$45.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$28.1M | -$627.6M | -$166.6M | -$85.9M | -$45.7M | |
| Basic EPS (Cont. Ops) | -$0.34 | -$3.94 | -$0.80 | -$0.38 | -$0.19 | |
| Diluted EPS (Cont. Ops) | -$0.34 | -$3.94 | -$0.80 | -$0.38 | -$0.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $19.8M | -$570.4M | -$70.2M | $7.9M | $15.7M | |
| EBIT | -$17.4M | -$637.1M | -$138.5M | -$73.3M | -$52.2M | |
| Revenue (Reported) | $168.1M | $294.9M | $352.3M | $435.5M | $535.2M | |
| Operating Income (Reported) | -$16.2M | -$622.9M | -$138.5M | -$73.3M | -$52.2M | |
| Operating Income (Adjusted) | -$17.4M | -$637.1M | -$138.5M | -$73.3M | -$52.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $53.7M | $85.9M | $97.2M | $119.7M | $144M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $40.1M | $101.4M | $87.7M | $106.9M | $108.8M | |
| Gross Profit | $13.6M | -$15.5M | $9.5M | $12.8M | $35.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.3M | $7.4M | $6.3M | $6.6M | $8.9M | |
| Selling, General & Admin | $12.8M | $42M | $25.5M | $30M | $45.9M | |
| Other Inc / (Exp) | -$852K | $25.6M | -$3M | -$1.6M | $11.5M | |
| Operating Expenses | $16M | $49.4M | $31.7M | $36.6M | $54.9M | |
| Operating Income | -$2.4M | -$64.9M | -$22.2M | -$23.8M | -$19.7M | |
| Net Interest Expenses | $2.3M | $391K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$5.6M | -$39.6M | -$24.8M | -$24.7M | -$7.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$263K | $576K | $648K | $1.1M | $542K | |
| Net Income to Company | -$5.3M | -$40.2M | -$25.2M | -$25.5M | -$8.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.3M | -$40.2M | -$25.2M | -$25.5M | -$8.2M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.21 | -$0.11 | -$0.11 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.21 | -$0.11 | -$0.11 | -$0.03 | |
| Weighted Average Basic Share | $178.6M | $195.8M | $221.7M | $229.3M | $248.4M | |
| Weighted Average Diluted Share | $178.6M | $195.8M | $221.7M | $229.3M | $248.4M | |
| EBITDA | $6.9M | -$21.7M | -$4.9M | -$2.7M | -$3.3M | |
| EBIT | -$3.2M | -$39.2M | -$22.2M | -$23.8M | -$19.7M | |
| Revenue (Reported) | $53.7M | $85.9M | $97.2M | $119.7M | $144M | |
| Operating Income (Reported) | -$2.4M | -$64.9M | -$22.2M | -$23.8M | -$19.7M | |
| Operating Income (Adjusted) | -$3.2M | -$39.2M | -$22.2M | -$23.8M | -$19.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.8M | $222.4M | $122.7M | $100.3M | $110.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $24.8M | $48.8M | $33.4M | $71.1M | $85.5M | |
| Inventory | $384K | $530K | $283K | $347K | $482K | |
| Prepaid Expenses | $4.1M | $24.4M | $28.2M | $27.2M | $27.3M | |
| Other Current Assets | -- | -- | -- | -- | $9.9M | |
| Total Current Assets | $61.3M | $324.7M | $236.5M | $244.8M | $288.6M | |
| Property Plant And Equipment | $5M | $14.4M | $19.3M | $18.6M | $26.5M | |
| Long-Term Investments | -- | -- | $23.7M | $26.4M | $31.7M | |
| Goodwill | $200.6M | $346.4M | $309.9M | $326M | $326M | |
| Other Intangibles | $114.5M | $191.2M | $149.2M | $129.7M | $115.5M | |
| Other Long-Term Assets | -- | -- | $24.2M | $25.5M | $2.7M | |
| Total Assets | $391M | $887.1M | $773.3M | $775.7M | $792.3M | |
| Accounts Payable | $10.1M | $19.9M | $33.1M | $57.4M | $36.7M | |
| Accrued Expenses | $35.2M | $55.9M | $57M | $56.3M | $79.2M | |
| Current Portion Of Long-Term Debt | $10.3M | $23K | $7.4M | $7.6M | $19K | |
| Current Portion Of Capital Lease Obligations | -- | -- | $3.5M | $3.6M | $3M | |
| Other Current Liabilities | $138K | $38.6M | $17.7M | $4.4M | $413K | |
| Total Current Liabilities | $85.3M | $152.8M | $171.1M | $182.9M | $201.6M | |
| Long-Term Debt | $82.7M | $65K | $7.1M | $19K | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $530.4M | $180.9M | $196.5M | $202.7M | $219.9M | |
| Common Stock | $700K | $1.9M | $2M | $2.1M | $2.2M | |
| Other Common Equity Adj | -- | -- | -$55.2M | -$33.1M | -$24.6M | |
| Common Equity | -$139.4M | $706.2M | $576.8M | $573M | $572.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$139.4M | $706.2M | $576.8M | $573M | $572.4M | |
| Total Liabilities and Equity | $391M | $887.1M | $773.3M | $775.7M | $792.3M | |
| Cash and Short Terms | $11.8M | $222.4M | $122.7M | $100.3M | $110.2M | |
| Total Debt | $93M | $88K | $14.5M | $7.6M | $19K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.6M | $174.2M | $94.4M | $67.5M | $209.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $23.2M | $52M | $39.7M | $100.3M | $81.6M | |
| Inventory | $430K | $524K | $323K | $254K | $432K | |
| Prepaid Expenses | $5.6M | $29.7M | $28.9M | $29.5M | $37.3M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $65.2M | $294M | $218.4M | $229.2M | $396.6M | |
| Property Plant And Equipment | $4.6M | $14M | $19.3M | $19.6M | $34.6M | |
| Long-Term Investments | -- | $22.1M | $23M | $25M | $29.3M | |
| Goodwill | $202.2M | $336.7M | $316.1M | $323.3M | $326M | |
| Other Intangibles | $109.7M | $180M | $146M | $119.8M | $115.3M | |
| Other Long-Term Assets | -- | -- | $24.7M | $25.3M | -- | |
| Total Assets | $393.6M | $859.7M | $757.9M | $745.4M | $906.7M | |
| Accounts Payable | $17.2M | $20.7M | $21.4M | $51.4M | $40M | |
| Accrued Expenses | $32.7M | $52.6M | $60.2M | $63.4M | $66.8M | |
| Current Portion Of Long-Term Debt | -- | $7.7M | $7.2M | $23K | $15K | |
| Current Portion Of Capital Lease Obligations | -- | -- | $3.3M | $3.5M | $3M | |
| Other Current Liabilities | $140K | $8.1M | $4.7M | $4.7M | -- | |
| Total Current Liabilities | $89.8M | $134.3M | $144.8M | $174.9M | $170.7M | |
| Long-Term Debt | $85.4M | $7.4M | $35K | $13K | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $546.7M | $168.7M | $164M | $194.9M | $195.8M | |
| Common Stock | $24K | $2M | $2.1M | $2.2M | $2.4M | |
| Other Common Equity Adj | -- | -- | -$46.2M | -$36.7M | -$34.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$153.1M | $691.1M | $593.9M | $550.5M | $710.8M | |
| Total Liabilities and Equity | $393.6M | $859.7M | $757.9M | $745.4M | $906.7M | |
| Cash and Short Terms | $10.6M | $174.2M | $94.4M | $67.5M | $209.8M | |
| Total Debt | $95.9M | $15.2M | $7.2M | $36K | $15K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$30.3M | -$592.8M | -$181.6M | -$85.5M | -$63M | |
| Depreciation & Amoritzation | $35M | $59.4M | $68.5M | $77.3M | $72.6M | |
| Stock-Based Compensation | -- | $489.5M | $89.8M | $35.3M | $54.5M | |
| Change in Accounts Receivable | -$9.5M | -$37.7M | -$10.7M | -$30.9M | -$7.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.1M | -$63.3M | -$3.5M | $14.9M | $81.9M | |
| Capital Expenditures | $18.8M | $33.4M | $47.6M | $49.1M | $64.3M | |
| Cash Acquisitions | -$3.9M | -$103.9M | -$20K | -- | -- | |
| Cash From Investing | -$22.7M | -$132.3M | -$54.8M | -$47.6M | -$62.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -$313.2M | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$21K | -$97M | -$21K | -$7.4M | -$7.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $93K | $231.3M | -- | -- | -- | |
| Cash From Financing | $10.1M | $410.4M | -$21K | -$596K | -$7.6M | |
| Beginning Cash (CF) | $8.2M | $11.8M | $222.4M | $159M | $125.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.5M | $214.7M | -$58.3M | -$33.3M | $11.6M | |
| Ending Cash (CF) | $11.8M | $222.4M | $159M | $125.8M | $135.2M | |
| Levered Free Cash Flow | -$1.7M | -$96.7M | -$51M | -$34.3M | $17.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.3M | -$40.2M | -$25.2M | -$25.5M | -$8.2M | |
| Depreciation & Amoritzation | $10.1M | $17.5M | $17.3M | $21.1M | $16.4M | |
| Stock-Based Compensation | -- | $37.2M | $10.6M | $6.7M | $12.8M | |
| Change in Accounts Receivable | -$2.5M | -$17.6M | -$8.8M | -$18.1M | $2.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3M | -$25.2M | -$18.8M | -$14.6M | -$30.8M | |
| Capital Expenditures | $4.3M | $11.6M | $10.3M | $12.4M | $17.5M | |
| Cash Acquisitions | -- | -$7.9M | -- | -- | -- | |
| Cash From Investing | -$4.2M | -$19.5M | -$8.9M | -$11M | -$15M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5K | -- | -$7.4M | -$7.6M | -$5K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5K | -- | -$580K | -$7.6M | $144M | |
| Beginning Cash (CF) | $11.8M | $222.4M | $159M | $125.8M | $135.2M | |
| Foreign Exchange Rate Adjustment | -$271K | -$3.5M | $766K | $134K | $2.2M | |
| Additions / Reductions | -$928K | -$44.7M | -$28.3M | -$33.1M | $98.2M | |
| Ending Cash (CF) | $10.6M | $174.2M | $131.5M | $92.8M | $235.7M | |
| Levered Free Cash Flow | -$954K | -$36.8M | -$29.1M | -$27M | -$48.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$28.1M | -$627.6M | -$166.6M | -$85.9M | -$45.7M | |
| Depreciation & Amoritzation | $37.1M | $66.7M | $68.3M | $81.1M | $67.8M | |
| Stock-Based Compensation | -- | $526.7M | $63.2M | $31.5M | $60.6M | |
| Change in Accounts Receivable | -$13.8M | -$52.7M | -$1.9M | -$40.2M | $13.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.7M | -$91.8M | $2.9M | $19.1M | $65.7M | |
| Capital Expenditures | $16.9M | $40.7M | $46.3M | $51.2M | $69.3M | |
| Cash Acquisitions | -$3.9M | -$111.8M | $7.9M | -- | -- | |
| Cash From Investing | -$20.8M | -$147.6M | -$44.2M | -$49.6M | -$66.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -$313.2M | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$21K | -$97M | -$7.4M | -$7.6M | -$22K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $10M | $410.4M | -$601K | -$7.6M | $144M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $935K | $171M | -$41.9M | -$38.1M | $142.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$5.3M | -$132.5M | -$43.4M | -$32.1M | -$3.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.3M | -$40.2M | -$25.2M | -$25.5M | -$8.2M | |
| Depreciation & Amoritzation | $10.1M | $17.5M | $17.3M | $21.1M | $16.4M | |
| Stock-Based Compensation | -- | $37.2M | $10.6M | $6.7M | $12.8M | |
| Change in Accounts Receivable | -$2.5M | -$17.6M | -$8.8M | -$18.1M | $2.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3M | -$25.2M | -$18.8M | -$14.6M | -$30.8M | |
| Capital Expenditures | $4.3M | $11.6M | $10.3M | $12.4M | $17.5M | |
| Cash Acquisitions | -- | -$7.9M | -- | -- | -- | |
| Cash From Investing | -$4.2M | -$19.5M | -$8.9M | -$11M | -$15M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5K | -- | -$7.4M | -$7.6M | -$5K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5K | -- | -$580K | -$7.6M | $144M | |
| Beginning Cash (CF) | $11.8M | $222.4M | $159M | $125.8M | $135.2M | |
| Foreign Exchange Rate Adjustment | -$271K | -$3.5M | $766K | $134K | $2.2M | |
| Additions / Reductions | -$928K | -$44.7M | -$28.3M | -$33.1M | $98.2M | |
| Ending Cash (CF) | $10.6M | $174.2M | $131.5M | $92.8M | $235.7M | |
| Levered Free Cash Flow | -$954K | -$36.8M | -$29.1M | -$27M | -$48.3M | |
Get GENI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GENI
Sector
P/E ratio
--
16.92x
PEG ratio
--
0.17x
P/B ratio
3.60x
1.42x
Price / LTM sales
4.74x
0.68x
Growth Metrics
GENI
Sector
Revenue growth
20.28%
0.64%
Earnings growth
--
-1.02%
Revenue (5-year growth)
34.84%
3.61%
Earnings forecast
-$0.05
$0.24
Profitability
GENI
Sector
Profitability FY 2024
$128.7M
$456.7M
Return on invested capital
-7.77%
4.58%
Return on assets
-5.88%
2.72%
Return on equity
-7.77%
6.7%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
5
Balance Sheet
GENI
Sector
Total cash
$209.8M
$139.6M
Short term investments
--
$46.8M
Total assets
$792.3M
$1.4B
Long term debt
$15K
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
